These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29329059)

  • 1. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease.
    Perin S; Harrington KD; Lim YY; Ellis K; Ames D; Pietrzak RH; Schembri A; Rainey-Smith S; Salvado O; Laws SM; Martins RN; Villemagne VL; Rowe CC; Masters CL; Maruff P;
    J Affect Disord; 2018 Mar; 229():269-274. PubMed ID: 29329059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid burden and incident depressive symptoms in cognitively normal older adults.
    Harrington KD; Gould E; Lim YY; Ames D; Pietrzak RH; Rembach A; Rainey-Smith S; Martins RN; Salvado O; Villemagne VL; Rowe CC; Masters CL; Maruff P;
    Int J Geriatr Psychiatry; 2017 Apr; 32(4):455-463. PubMed ID: 27114112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
    Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
    J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
    [No Abstract]   [Full Text] [Related]  

  • 4. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.
    Donovan NJ; Hsu DC; Dagley AS; Schultz AP; Amariglio RE; Mormino EC; Okereke OI; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 46(1):63-73. PubMed ID: 25697700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T; Nagatsuka K
    Int J Geriatr Psychiatry; 2016 Aug; 31(8):920-8. PubMed ID: 26766490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults.
    Donovan NJ; Locascio JJ; Marshall GA; Gatchel J; Hanseeuw BJ; Rentz DM; Johnson KA; Sperling RA;
    Am J Psychiatry; 2018 Jun; 175(6):530-537. PubMed ID: 29325447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.
    Dang C; Harrington KD; Lim YY; Ames D; Hassenstab J; Laws SM; Yassi N; Hickey M; Rainey-Smith S; Robertson J; Sohrabi HR; Salvado O; Weinborn M; Villemagne VL; Rowe CC; Masters CL; Maruff P;
    J Alzheimers Dis; 2018; 65(4):1313-1325. PubMed ID: 30149452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
    J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.
    Hollands S; Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Harrington K; Porter T; Snyder P; Ames D; Fowler C; Rainey-Smith SR; Martins RN; Salvado O; Robertson J; Rowe CC; Masters CL; Maruff P;
    J Alzheimers Dis; 2017; 57(2):411-422. PubMed ID: 28234254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.
    Babulal GM; Ghoshal N; Head D; Vernon EK; Holtzman DM; Benzinger TLS; Fagan AM; Morris JC; Roe CM
    Am J Geriatr Psychiatry; 2016 Nov; 24(11):1095-1104. PubMed ID: 27426238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.
    Baker JE; Lim YY; Jaeger J; Ames D; Lautenschlager NT; Robertson J; Pietrzak RH; Snyder PJ; Villemagne VL; Rowe CC; Masters CL; Maruff P
    J Alzheimers Dis; 2018; 65(3):977-988. PubMed ID: 30103330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease.
    Buckley RF; Maruff P; Ames D; Bourgeat P; Martins RN; Masters CL; Rainey-Smith S; Lautenschlager N; Rowe CC; Savage G; Villemagne VL; Ellis KA;
    Alzheimers Dement; 2016 Jul; 12(7):796-804. PubMed ID: 26852195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's disease.
    Lim YY; Maruff P; Schindler R; Ott BR; Salloway S; Yoo DC; Noto RB; Santos CY; Snyder PJ
    Neurobiol Aging; 2015 Oct; 36(10):2709-15. PubMed ID: 26233262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hypertension on brain amyloid deposition and Alzheimer's disease signature neurodegeneration.
    Jeon SY; Byun MS; Yi D; Lee JH; Choe YM; Ko K; Sohn BK; Choi HJ; Lee JY; Lee DY;
    Neurobiol Aging; 2019 Mar; 75():62-70. PubMed ID: 30553154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults: Effects of Alzheimer's Disease Pathology and Cognitive Decline.
    Johansson M; Stomrud E; Johansson PM; Svenningsson A; Palmqvist S; Janelidze S; van Westen D; Mattsson-Carlgren N; Hansson O
    Biol Psychiatry; 2022 Jul; 92(1):34-43. PubMed ID: 35346458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β.
    Fernando WMADB; Rainey-Smith SR; Gardener SL; Villemagne VL; Burnham SC; Macaulay SL; Brown BM; Gupta VB; Sohrabi HR; Weinborn M; Taddei K; Laws SM; Goozee K; Ames D; Fowler C; Maruff P; Masters CL; Salvado O; Rowe CC; Martins RN;
    J Alzheimers Dis; 2018; 61(4):1589-1598. PubMed ID: 29376865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults.
    Hollands S; Lim YY; Buckley R; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Lautenschlager N; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P
    J Alzheimers Dis; 2015; 43(2):677-86. PubMed ID: 25114076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta and depression in healthy older adults: a systematic review.
    Harrington KD; Lim YY; Gould E; Maruff P
    Aust N Z J Psychiatry; 2015 Jan; 49(1):36-46. PubMed ID: 25414381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.